Means Investment Company’s Thermo Fisher Scientific TMO Stock Holding History

Means Investment Company’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-371	Closed	-$230K	–	212
2024 Q3	$230K	Sell	371 -45	-11%	-$26.6K	0.03%	189
2024 Q2	$230K	Sell	416 -2	-0.5%	-$1.15K	0.03%	182
2024 Q1	$243K	Buy	+418	New	+$235K	0.03%	179
2023 Q4	–	Sell	-858	Closed	-$435K	–	199
2023 Q3	$435K	Buy	858 +60	+8%	+$32K	0.07%	129
2023 Q2	$416K	Buy	798 +62	+8%	+$33.5K	0.07%	132
2023 Q1	$424K	Sell	736 -50	-6%	-$28.2K	0.07%	130
2022 Q4	$433K	Sell	786 -43	-5%	-$22.8K	0.09%	127
2022 Q3	$420K	Buy	829 +1	+0.1%	+$560	0.09%	126
2022 Q2	$450K	Hold	828	–	–	0.1%	120
2022 Q1	$489K	Buy	828 +50	+6%	+$28.7K	0.09%	119
2021 Q4	$519K	Buy	778 +107	+16%	+$66.8K	0.09%	114
2021 Q3	$383K	Buy	671 +1	+0.1%	+$549	0.08%	133
2021 Q2	$338K	Buy	670 +200	+43%	+$94.4K	0.07%	149
2021 Q1	$215K	Hold	470	–	–	0.05%	166
2020 Q4	$232K	Buy	+470	New	+$220K	0.05%	158

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Means Investment Company's TMO Position: Q4 2024 in Review

Means Investment Company sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 371 shares — an estimated $230K sold.

Means Investment Company first reported a position in TMO in Q4 2020 and held it in 15 quarters. The position peaked at $519K in Q4 2021. 2,617 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

Means Investment Company reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
Means Investment Company sold 371 Thermo Fisher Scientific shares in Q4 2024, an estimated $230K.
Means Investment Company first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 15 quarters.
Means Investment Company's Thermo Fisher Scientific position peaked at $519K in Q4 2021.
2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Means Investment Company's 13F filing for Q4 2024, filed 24 Jan 2025.